EP3789385A1
|
|
Method for preparing lenalidomide
|
CN110862346A
|
|
Levatinib mesylate acetic acid compound crystal form, preparation method and application thereof
|
CN111150711A
|
|
Tofacitinib controlled-release tablet, preparation method and application thereof
|
CN111196759A
|
|
Preparation method of cinacalcet hydrochloride and intermediate thereof
|
CN110872322A
|
|
Preparation method of cefaloside acetate monohydrate and intermediate thereof
|
CN110818634A
|
|
Refining method of lervatinib mesylate
|
CN110818606A
|
|
Preparation method of ezetimibe and intermediate thereof
|
CN110804038A
|
|
Preparation method of tedizolid phosphate and intermediate thereof
|
CN109096276A
|
|
The preparation method of moxifloxacin hydrochloride and its intermediate
|
CN109180499A
|
|
The preparation method of rasagiline mesilate and its intermediate
|
CN108947863A
|
|
The preparation method of zucapsaicin and its intermediate
|
CN108912020A
|
|
Ao Dangka is replaced and its preparation method of intermediate
|
CN108147999A
|
|
The preparation method of dexmedetomidine hydrochloride and its intermediate
|
CN108084115A
|
|
The preparation method of body of Pramipexole dihydrochloride and its intermediate
|
CN108191792A
|
|
A kind of preparation method of hydrobromic acid Vortioxetine and its intermediate
|
CN107955002A
|
|
The preparation method of Eliquis and its intermediate
|
CN108178756A
|
|
The preparation method of palonosetron Hcl and its intermediate
|
CN109942633A
|
|
Tenofovir Chinese mugwort draws the preparation method of phenol amine intermediate
|
CN109942632A
|
|
Tenofovir Chinese mugwort draws the preparation method of phenol amine intermediate
|
CN108070003A
|
|
Tenofovir Chinese mugwort draws half fumarate crystal form of phenol amine and preparation method and application
|